Back
Halozyme Therapeutics Quote, Financials, Valuation and Earnings
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
54
HALO
Halozyme Therapeutics
Last Price:
59.25
Seasonality Move:
10.79%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.Halozyme Therapeutics Price Quote
$59.25
-0.01 (-0.44%)
(Updated: September 21, 2024 at 4:44 AM ET)
Halozyme Therapeutics Key Stats
Buy
54
Halozyme Therapeutics (HALO)
is a Buy
Day range:
$58.71 - $59.83
52-week range:
$32.83 - $65.53
Dividend yield:
0%
P/E ratio:
28.22
P/S ratio:
8.88
P/B ratio:
25.94%
Volume:
1.5M
Avg. volume:
1.3M
1-year change:
49.65%
Market cap:
$7.5B
Revenue:
$829.3M
EPS:
$2.58
How Much Does Halozyme Therapeutics Make?
-
How Much Are Halozyme Therapeutics's Sales Annually?
HALO Revenues are $829.3M -
How Much Profit Does Halozyme Therapeutics's Make A Year?
HALO net income is $281.6M
Is Halozyme Therapeutics Growing As A Company?
-
What Is Halozyme Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.05% -
What Is Halozyme Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0.29%
Halozyme Therapeutics Stock Price Performance
-
Did Halozyme Therapeutics Stock Go Up Last Month?
Halozyme Therapeutics share price went down by -2.74% last month -
Did HALO's Share Price Rise Over The Last Year?
HALO share price rose by 49.65% over the past 1 year
What Is Halozyme Therapeutics 52-Week High & Low?
-
What Is Halozyme Therapeutics’s 52-Week High Share Price?
Halozyme Therapeutics has traded as high as $65.53 over the past 52 weeks -
What Is Halozyme Therapeutics’s 52-Week Low Share Price?
Halozyme Therapeutics has traded as low as $32.83 over the past 52 weeks
Halozyme Therapeutics Price To Free Cash Flow
-
Is Halozyme Therapeutics Stock Overvalued?
Halozyme Therapeutics is trading at a price to free cash flow ratio of 18.99 -
Is Halozyme Therapeutics Stock Undervalued?
Halozyme Therapeutics EV to Free Cash Flow ratio is 20.77 -
What Is Halozyme Therapeutics’s Price Earnings Growth Ratio?
HALO PEG ratio is 0.45 -
Is Halozyme Therapeutics Trading At A Premium To Earnings?
Halozyme Therapeutics EV to EBIT ratio is 19.47
Is It Risky To Buy Halozyme Therapeutics?
-
How Much Debt Does Halozyme Therapeutics Have?
Total long term debt quarterly is $1.5B -
How Much Cash Does Halozyme Therapeutics Have?
Cash and short term investments quarterly total is $529M -
What Is Halozyme Therapeutics’s Book Value Per Share?
Book value per share is 2.29
Is Halozyme Therapeutics Cash Flow Positive?
-
What Is HALO Cash Flow From Operations?
Cash flow from operations (TTM) is $420M -
What Is Halozyme Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$236.8M -
What Is Halozyme Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$216.5M
Halozyme Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
HALO return on invested capital is 19.96% -
What Is Halozyme Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is 18.24% -
What Is HALO Return On Equity?
ROE is a measure of profitability and is 177.29%
Halozyme Therapeutics Earnings Date & Stock Price
-
What Is Halozyme Therapeutics's Stock Price Today?
A single share of HALO can be purchased today for 59.26 -
What Is Halozyme Therapeutics’s Stock Symbol?
Halozyme Therapeutics trades on the nasdaq under the ticker symbol: HALO -
When Is Halozyme Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Halozyme Therapeutics is scheduled on November 6, 2024 -
When Is HALO's next ex-dividend date?
Halozyme Therapeutics's next ex-dividend date is September 21, 2024 -
How To Buy Halozyme Therapeutics Stock?
You can buy Halozyme Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Halozyme Therapeutics Competitors
-
Who Are Halozyme Therapeutics's Competitors?
Below is a list of companies who compete with Halozyme Therapeutics or are related in some way:
Halozyme Therapeutics Dividend Yield
-
What Is HALO Dividend Yield?
Halozyme Therapeutics’s dividend yield currently is 0% -
What Is Halozyme Therapeutics’s Payout Ratio?
Halozyme Therapeutics’s payout ratio is 0% -
When Did Halozyme Therapeutics Last Pay A Dividend?
The latest dividend pay date is September 21, 2024 -
What Is Halozyme Therapeutics’s Dividend Per Share?
Halozyme Therapeutics pays a dividend of $0.00 per share
Halozyme Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 28.57% | 20.1% |
| Revenue: | 4.67% | 12.89% |
Analyst Recommendations
| Buy Recommendations: | 4 |
|---|---|
| Hold Recommendations: | 4 |
| Sell Recommendations: | 0 |
| Price Target: | 61.10 |
| Upside from Last Price: | 3.1% |